N Herrmann

Summary

Country: Canada

Publications

  1. ncbi Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
    N Herrmann
    Division of Geriatric Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychopharmacol 20:90-3. 2000
  2. ncbi Risperidone for the treatment of behavioral disturbances in dementia: a case series
    N Herrmann
    Sunnybrook Health Science Centre, University of Toronto, Royal Ottawa Hospital, University of Ottawa, Canada
    J Neuropsychiatry Clin Neurosci 10:220-3. 1998
  3. ncbi From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia
    N Herrmann
    University of Toronto, Ontario
    Can J Psychiatry 42:51S-64S. 1997
  4. ncbi Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae
    A B Gold
    Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue Rm FG 05, Toronto, ON M4N 3M5, Canada
    Curr Drug Targets 12:243-55. 2011
  5. doi Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease
    W Swardfager
    Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Brain Behav Immun 25:1264-71. 2011

Collaborators

  • A B Gold
  • W Swardfager
  • K L Lanctot
  • P R Albert
  • M Daigle
  • P Shammi
  • S Marzolini
  • A Kiss
  • P I Oh
  • M Saleem

Detail Information

Publications5

  1. ncbi Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
    N Herrmann
    Division of Geriatric Psychiatry, University of Toronto, Ontario, Canada
    J Clin Psychopharmacol 20:90-3. 2000
    ..Gabapentin may have a role in treating a subgroup of dementia patients with severe behavioral disorders who have not responded to neuroleptics...
  2. ncbi Risperidone for the treatment of behavioral disturbances in dementia: a case series
    N Herrmann
    Sunnybrook Health Science Centre, University of Toronto, Royal Ottawa Hospital, University of Ottawa, Canada
    J Neuropsychiatry Clin Neurosci 10:220-3. 1998
    ..Risperidone, in low doses, was well tolerated; 50% of patients experienced significant improvement, although 50% experienced some extrapyramidal symptoms...
  3. ncbi From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia
    N Herrmann
    University of Toronto, Ontario
    Can J Psychiatry 42:51S-64S. 1997
    ....
  4. ncbi Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae
    A B Gold
    Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue Rm FG 05, Toronto, ON M4N 3M5, Canada
    Curr Drug Targets 12:243-55. 2011
    ....
  5. doi Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease
    W Swardfager
    Neuropsychopharmacology Research Group, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    Brain Behav Immun 25:1264-71. 2011
    ..To assess serum brain derived neurotrophic factor (BDNF) concentrations as a correlate of cardiopulmonary fitness and as a predictor of cognitive performance in subjects with coronary artery disease (CAD)...